NASDAQ$PRVA
Privia Health Group, Inc · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
Privia Health Group, Inc. reported revenue of $521.2 million for the second quarter of 2025.
The company achieved 23.4% year-over-year revenue growth driven by an increase in implemented providers and attributed lives. Operating income was $3.3 million with net income attributable to the company of $2.7 million. Value-based care revenue grew significantly, reflecting continued progress in risk-based arrangements.
- Revenue reached $521.2 million, up 23.4% from Q2 2024.
- Implemented providers grew 13.8% to 5,125 and attributed lives increased 15.2% to 1.38 million.
- Value-based care revenue rose to 29.3% of total revenue, supported by higher shared savings and capitated arrangements.
- Adjusted EBITDA increased 31.6% to $29.0 million, demonstrating operating leverage.
Headline financials
Revenue & EPS history
Privia Health · Revenue · Quarterly
$521M
Revenue by segment
Privia Health · $521M total across 6 segments · Q2 2025
- FFS Patient Care$331M—63.6%
- Capitated Revenue$75.5M—14.5%
- Shared Savings$60M—11.5%
- FFS Administrative Services$35.1M—6.7%
- Care Management Fees PMPM$16.9M—3.2%
- Other Revenue$2.12M—0.4%
Forward guidance
The company continues to expand its provider base and attributed lives while advancing value-based care arrangements across existing and new markets.
Tailwinds
- Strong growth in implemented providers and attributed lives
- Increasing contribution from value-based care programs
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+3.5%
Avg return
Earnings day
+4.1%
Avg return
5 days after
+1.3%
Avg return
30 days after
64%
16 / 25 earnings
Positive
+28.3%
Q1 2022
Best reaction
-8.8%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -0.1% | -4.1% | -9.9% | |
| Q4 2025 | +9.9% | +4.9% | -11.6% | |
| Q3 2025 | -4.3% | -2.8% | -4.7% | |
| Q1 2025 | +7.3% | +4.2% | -0.6% | |
| Q4 2024 | +5.8% | +6.1% | -6.1% | |
| Q3 2024 | +0.7% | +6.7% | +0.1% | |
| Q2 2024 | +4.4% | +9.7% | +2.1% | |
| Q1 2024 | -4.7% | -4.3% | -9.1% | |
| Q4 2023 | +9.4% | +11.6% | -2.0% | |
| Q3 2023 | +9.7% | +9.0% | +6.0% | |
| Q2 2023 | +1.6% | -1.2% | -2.3% | |
| Q1 2023 | +7.3% | +7.2% | -8.3% | |
| Q4 2022 | +4.6% | +6.3% | +1.7% | |
| Q3 2022 | +5.3% | +6.2% | -9.7% | |
| Q2 2022 | +0.6% | -4.6% | +13.3% | |
| Q1 2022 | +28.3% | +25.1% | +41.0% | |
| Q4 2019 | -2.0% | +6.4% | -3.5% | |
| Q4 2021 | +3.3% | +7.5% | +10.4% | |
| Q3 2021 | +12.3% | +18.3% | -14.5% | |
| Q3 2020 | +12.3% | +18.3% | -14.5% | |
| Q2 2020 | -8.8% | -14.8% | -26.5% | |
| Q2 2021 | -8.8% | -14.8% | -26.5% | |
| Q1 2020 | -2.2% | +0.7% | +34.8% | |
| Q4 2020 | -2.2% | +0.7% | +34.8% | |
| Q1 2021 | -1.1% | +0.9% | +39.1% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro